Announcements Trials
Browse Landscape

Phase

Phase 3 5

Status

Recruiting 3Terminated 2Active not recruiting 1

Sponsor Class

OTHER 27INDUSTRY 6

Study Type

Interventional 5Observational 1

Sponsor

Cancer Type

Classical hematology 6Gastrointestinal 2

Conditions

Carcinoma, Non-Small-Cell Lung 927Neoplasms 612Breast Neoplasms 611Colorectal Neoplasms 458Neoplasm Metastasis 398Ovarian Neoplasms 333Prostatic Neoplasms 316Melanoma 316Lung Neoplasms 294Multiple Myeloma 293Recurrence 281Squamous Cell Carcinoma of Head and Neck 248Stomach Neoplasms 232Pancreatic Neoplasms 231Leukemia, Myeloid, Acute 224Triple Negative Breast Neoplasms 193Endometrial Neoplasms 190Carcinoma, Renal Cell 183Lymphoma, Non-Hodgkin 178Carcinoma, Hepatocellular 178Small Cell Lung Carcinoma 166Leukemia, Lymphocytic, Chronic, B-Cell 158Advanced Solid Tumors 158Lymphoma, Follicular 150Lymphoma, Large B-Cell, Diffuse 141Urinary Bladder Neoplasms 140Lymphoma 138Advanced Solid Tumor 137Uterine Cervical Neoplasms 136Head and Neck Neoplasms 134

Interventions

apixaban 3abelacimab 2MAA868 2isoquercitrin 1edoxaban 1Rivaroxaban 1Heparin, Low-Molecular-Weight 1Dalteparin 1Dabigatran 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
INDUSTRY × Venous Thromboembolism × 1 year × Clear all
NCT07493304 2026-05-29

ROXI-CAT-II

Regeneron Pharmaceuticals

Phase 3 Recruiting
1,600 enrolled
Classical hematology

Neoplasms, Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

NCT07410117 2026-05-27

ROXI-CAT-I

Regeneron Pharmaceuticals

Phase 3 Recruiting
1,120 enrolled
Classical hematology

Hemorrhage, Neoplasms, Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

NCT04618913 2026-05-26

VICTORIE

Pfizer

Active not recruiting
1 enrolled
Classical hematology

Embolism, Neoplasms, Venous Thromboembolism

NCT05171075 2026-04-17

MAGNOLIA

Anthos Therapeutics, Inc.

Phase 3 Terminated
417 enrolled
Classical hematologyGastrointestinal

Gastrointestinal Neoplasms, Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

NCT05171049 2026-02-23

ASTER

Anthos Therapeutics, Inc.

Phase 3 Terminated
1,150 enrolled
Classical hematology

Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

NCT06861088 2026-02-02

CATIQ P3

Quercis Pharma AG

Phase 3 Recruiting
480 enrolled
Classical hematologyGastrointestinal

Pancreatic Neoplasms, Pulmonary Embolism, Thromboembolism, Venous Thrombosis, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡